Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02526277 · ClinicalTrials.gov registry record · NA

A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome

A NA study of Restless Legs Syndrome, sponsored by Ariane Park.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02526277 is a NA study of Restless Legs Syndrome that has completed, run by Ariane Park. The registered enrollment target is 28 participants, below the 94-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02526277, a NA study of Restless Legs Syndrome, has completed, sponsored by Ariane Park.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether the MMF07 Foot Massager and/ or heat therapy may improve symptoms of restless legs syndrome (RLS). It will also assess the effect of the MMF07 Foot Massager and/ or heat on quality of life and sleep in people affected by RLS. Participants will be randomly assigned to one of four treatment groups; 1. MMF07 Foot Massager device 2. Heat therapy 3. Heat therapy and the MMF07 Foot Massage device 4. Neither heat nor MMF07 Foot Massager device (no treatment group)

Conditions Studied

Interventions

  • DEVICE MMF07 Foot Massager
  • DEVICE Heat Therapy

Study Locations (1)

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2016-01-06
Est. Completion 2018-09-25
Phase NA

Sponsor

Ariane Park

1 total trials

What the Registry Record Tells You About NCT02526277

The ClinicalTrials.gov registry entry for NCT02526277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 94-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (70% lower). The listed sponsor is Ariane Park, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Restless Legs Syndrome appearing as the primary indexed condition, and to 2 interventions - of which MMF07 Foot Massager is the first listed.

NCT02526277 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02526277 about?

NCT02526277 is a clinical study titled "A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome". The purpose of this study is to assess whether the MMF07 Foot Massager and/ or heat therapy may improve symptoms of restless legs syndrome (RLS). It will also assess the effect of the MMF07 Foot Massager and/ or heat on quality of life and sleep in people affected by RLS. Participants will be random...

What is the current status of trial NCT02526277?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2016-01-06. Estimated completion is 2018-09-25.

What conditions does trial NCT02526277 study?

This clinical trial studies the following conditions: Restless Legs Syndrome.

What interventions are being tested in trial NCT02526277?

The interventions under investigation include: MMF07 Foot Massager (DEVICE), Heat Therapy (DEVICE).

Who is sponsoring clinical trial NCT02526277?

This trial is sponsored by Ariane Park, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02526277 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Restless Legs Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.